These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 33773605

  • 81.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 82.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 83. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients.
    Wareham NE, Mocroft A, Sengeløv H, Da Cunha-Bang C, Gustafsson F, Heilmann C, Iversen M, Kirkby NS, Rasmussen A, Sørensen SS, Lundgren JD, MATCH in PERSIMUNE study group.
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1569-1580. PubMed ID: 29804164
    [Abstract] [Full Text] [Related]

  • 84. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
    Colombini E, Guzzo I, Morolli F, Longo G, Russo C, Lombardi A, Merli P, Barzon L, Murer L, Piga S, Ciofi Degli Atti ML, Locatelli F, Dello Strologo L.
    Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938
    [Abstract] [Full Text] [Related]

  • 85. Gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder after kidney transplantation: A case report.
    Yoshimura Y, Suwabe T, Fujiki A, Kaji D, Asano-Mori Y, Oba Y, Mizuno H, Yamanouchi M, Tanaka K, Hasegawa E, Miki K, Yokoyama T, Namamura Y, Ishii Y, Yamashita S, Kono K, Kinowaki K, Takazawa Y, Sawa N, Ubara Y.
    Clin Nephrol; 2024 May; 101(5):250-256. PubMed ID: 38329919
    [Abstract] [Full Text] [Related]

  • 86. Orbital Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a 13-year-old girl with cord blood transplantation.
    Shigemura T, Maruyama Y, Shigeto S, Nakazawa Y, Kanno H.
    Transpl Infect Dis; 2021 Jun; 23(3):e13536. PubMed ID: 33264446
    [Abstract] [Full Text] [Related]

  • 87. Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities.
    Al Hamed R, Bazarbachi AH, Mohty M.
    Bone Marrow Transplant; 2020 Jan; 55(1):25-39. PubMed ID: 31089285
    [Abstract] [Full Text] [Related]

  • 88. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
    Mentzer SJ, Perrine SP, Faller DV.
    Transpl Infect Dis; 2001 Sep; 3(3):177-85. PubMed ID: 11493400
    [Abstract] [Full Text] [Related]

  • 89. Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT.
    Kinch A, Hallböök H, Arvidson J, Sällström K, Bondeson K, Pauksens K.
    Leuk Lymphoma; 2018 May; 59(5):1172-1179. PubMed ID: 28831836
    [Abstract] [Full Text] [Related]

  • 90. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?
    Greenfield HM, Gharib MI, Turner AJ, Guiver M, Carr T, Will AM, Wynn RF.
    Pediatr Blood Cancer; 2006 Aug; 47(2):200-5. PubMed ID: 16206207
    [Abstract] [Full Text] [Related]

  • 91. Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation.
    Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Shiratori S, Miyakoshi S, Ishiyama K, Ikegame K, Matsuhashi Y, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R.
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1441-1449. PubMed ID: 30794929
    [Abstract] [Full Text] [Related]

  • 92. Chorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virus.
    Demols PF, Cochaux PM, Velu T, Caspers-Velu L.
    Br J Ophthalmol; 2001 Jan; 85(1):93-5. PubMed ID: 11133721
    [Abstract] [Full Text] [Related]

  • 93. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A, Nazzari C, Verzaro S, Latte MC, Fabri G, Scateni S, Raggi C, Lubrano R, Mancini C.
    New Microbiol; 2006 Oct; 29(4):231-41. PubMed ID: 17201089
    [Abstract] [Full Text] [Related]

  • 94. Epstein-Barr virus-related lymphoproliferative disorder induced by equine anti-thymocyte globulin therapy.
    Viola GM, Zu Y, Baker KR, Aslam S.
    Med Oncol; 2011 Dec; 28(4):1604-8. PubMed ID: 20680523
    [Abstract] [Full Text] [Related]

  • 95. T-Cell Lymphoproliferative Disorders Following Allogeneic Bone Marrow Transplant: A Report of Two Cases and a Literature Review.
    Prabhakar N, Chiang H, Munoz Verdugo I, Hakimian A, Bufalino S, Bitran J.
    Cureus; 2024 May; 16(5):e59901. PubMed ID: 38854253
    [Abstract] [Full Text] [Related]

  • 96. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
    Ruf S, Behnke-Hall K, Gruhn B, Bauer J, Horn M, Beck J, Reiter A, Wagner HJ.
    J Clin Virol; 2012 Mar; 53(3):186-94. PubMed ID: 22182950
    [Abstract] [Full Text] [Related]

  • 97. Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type.
    Ergisi M, Ooi B, Salim O, Papalois V.
    Transplant Rev (Orlando); 2024 Apr; 38(2):100837. PubMed ID: 38430887
    [Abstract] [Full Text] [Related]

  • 98. Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphoma.
    Pfeffermann LM, Pfirrmann V, Huenecke S, Bremm M, Bonig H, Kvasnicka HM, Klingebiel T, Bader P, Rettinger E.
    Cytotherapy; 2018 Jun; 20(6):839-850. PubMed ID: 29754771
    [Abstract] [Full Text] [Related]

  • 99. A Case of Central Nervous System Post-Transplant Lymphoproliferative Disorder Following Haploidentical Stem Cell Transplantation in a Patient With Acute Lymphoblastic Leukemia.
    Zhu H, Li Q, Liu Y, Feng X, Deng Q.
    Cell Transplant; 2022 Jun; 31():9636897221117532. PubMed ID: 35979928
    [Abstract] [Full Text] [Related]

  • 100. [A clinical study of lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation].
    Xu LP, Huang XJ, Liu DH, Chen YH, Shi HX, Chen DB.
    Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):996-9. PubMed ID: 18478915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.